Category: News & Comments
Why Amgen's Stock Is Up Over $11 Today
Amgen's Stock Is Up Amgen ( AMGN ) is speeding towards reaching its true, fair value. In the Q2 financial results Amgen has beaten the most optimistic analysts’ expectations and negative investors who keep mourning the firm’s 35 years...
Read More
August 9, 2019
0
Jazz Pharmaceuticals: A New FDA Approval
People living with narcolepsy who develop cataplexy and excessive daytime sleepiness have a new treatment called Xywav, from Jazz Pharmaceuticals. Jazz Pharmaceuticals NEWS On July 21, 2020 the U.S. FDA approved Jazz Pharmaceuticals’ ( JAZZ ) product Xywav™ (calcium, magnesium, potassium...
Read More
July 22, 2020
0
Moderna's Future Growth
Moderna Inc COVID-19 Vaccine Candidate Moderna Inc ( MRNA ) announced the completion of the case accrual for the first interim analysis of Phase 3 COVE study of mRNA-1273, its COVID-19 vaccine candidate. The firm announced a significant increase in...
Read More
November 12, 2020
0
TCR2 Therapeutics Encouraging Oncology Results
TCR2 Therapeutics Announcement TCR2 Therapeutics ( TCRR ) - a clinical-stage immunotherapy company with a pipeline of novel T cell therapies for cancer, announced positive interim data from the first five patients treated in the Phase 1 portion of the TC-210 Phase 1/2...
Read More
July 27, 2020
0
Moderna's Successful COVID-19 Vaccine Results
Moderna Has Successful COVID-19 Vaccine Results and News Moderna’s Phase 3 study met statistical criteria with a vaccine efficacy of 94.5%. Moderna intends to submit for an Emergency Use Authorization (EUA) with U.S. FDA in the coming weeks and expects...
Read More
November 16, 2020
0
Why Akari Therapeutics Stock Price Rallied Today
Akari Therapeutics Stock Rallied Autoimmune and inflammatory disease treatments are works in progress with some approved products demonstrating remarkable efficacy. Still there are untreated inflammatory diseases, among them are those where the complement ( C5 ) and/or leukotriene ( LTB4...
Read More
August 14, 2019
0
Inovio: Good News About the Firm's COVID-19 Vaccine's Capability and Durability
Inovio Inovio’s COVID-19 Vaccine INO-4800 Accomplished the Following: Durable antibody and T cell responses in rhesus macaques for 4 months. Long-term protection in non-human primates challenged with SARS-CoV-2 virus 13 weeks from vaccination. No other vaccine has demonstrated...
Read More
July 30, 2020
0
AstraZeneca and Vertex Both Have Good News
AstraZeneca: Farxiga for Heart Failure with Reduced Ejection Fraction AstraZeneca ( AZN ) has good news. Many of them are extremely positive. However, the firm’s stock is still struggling to get this pharmaceutical company out of the oversold territory where it...
Read More
August 21, 2019
0
Amgen to Acquire Celgene's Product Otezla at $13.4 Billion
Amgen Agreement with Celgene for Otezla® In the News Amgen ( AMGN ) entered into an agreement with Celgene ( CELG ) to acquire worldwide rights to Otezla® (apremilast), the only oral, non-biologic treatment for psoriasis and psoriatic arthritis, and...
Read More
August 26, 2019
0
Regenxbio Announced the First Patient has been Dosed in the Phase I/II trial of RGX-111 for MPS I
Regenxbio Dosed First Patient with RGX-111 for MPS I Regenxbio ( RGNX ) has dosed the first patient with RGX-111 in the Phase I/II trial for the treatment of Mucopolysaccharidosis Type I ( MPS I ). About Regenxbio Product RGX-111...
Read More
December 1, 2020
0
Search ProhostBiotech
Popular Links
23andMe Holding Co (ME)Abbott Laboratories (ABT)AbbVie Inc (ABBV)AbCelleraAbeona Therapeutics (ABEO)Ablynx (ABLX)AbVitro IncAcadia (ACAD)Acceleron Pharma (XLRN)AcelRx Pharmaceuticals (ACRX).Acorda Therapeutics Inc (ACOR)Acumen Pharmaceuticals (ABOS)AdaptImmune Therapeutics (ADAP)Adaptive BiotechnologiesADC Therapeutics (ADCT)Adimab LLCAdvanced Micro Devices (AMD)Advaxis (ADXS)Adverum Biotechnologies (ADVM)Aerie Pharmaceuticals (AERI)AgenTus TherapeuticsAgenus (AGEN)AgeX Therapeutics (AGE)Agilent Technologies (A)Agilis Biotherapeutics IncAgios Pharmaceuticals (AGIO)AIM ImmunoTech (AIM)Aimmune Therapeutics (AIMT)Akari Therapeutics (AKTX)Akashi TherapeuticsAkcea Therapeutics (AKCA)Akebia Therapeutics Inc (AKBA)Akero Therapeutics (AKRO)Akous Inc (a wholly owned subsidiary of Eli Lilly Company)Alder BioPharmaceuticals (ALDR)Alexion Pharmaceuticals (ALXN)Alkermes (ALKS)Allergan Plc (AGN)Allogene TherapeuticsAllogene Therapeutics (ALLO)